Search Within

Craig Steven Sauter

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (12)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (27)
  2. Center for Hematologic Malignancies (27)
  3. Department of Medicine (27)
  4. Hematologic Malignancies, Division of (27)
  5. Molecular Imaging and Therapy Service (27)
  6. Radiology, Department of (27)

More Groups

People
  1. Heiko Schoder (20)
  2. Andrew Zelenetz (14)
  3. Miguel-Angel Perales (14)
  4. Maria Palomba (13)
  5. Anita Kumar (12)
  6. Ariela Noy (12)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (5)
  6. 2018 (1)

More Years

Publications
  1. Blood (12)
  2. Hematological Oncology (3)
  3. Leukemia and Lymphoma (2)
  4. Biology of Blood and Marrow Transplantation (1)
  5. Blood Advances (1)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Elsevier Inc. (4)
  3. Wiley Blackwell (3)
  4. Taylor & Francis Group (2)
  5. American Society for Clinical Investigation (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Prognostic value of FDG PET/CT before allogeneic and autologous stem cell transplantation for aggressive lymphoma
    Journal Article

    Ulaner, G. A.; Goldman, D. A.; Sauter, C. S.; Migliacci, J.; Lilienstein, J.; Gönen, M.; Schöder, H.; Moskowitz, C. H.; Zelenetz, A. D.
    Radiology (2015)

    Fulltext@MSK | Save
  • Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma
    Journal Article

    Sauter, C. S.; Matasar, M. J.; Meikle, J.; Schoder, H.; Ulaner, G. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation
    Journal Article

    Sauter, C. S.; Lechner, L.; Scordo, M.; Zheng, J.; Devlin, S. M.; Fleming, S. E.; Castro-Malaspina, H.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • The prognostic value of residual FDG-avidity prior to allogeneic stem cell transplantation for lymphoma
    Meeting Abstract

    Sauter, C. S.; Barker, J. N.; Zelenetz, A. D.; Fleming, S. E.; Castro-Malaspina, H.; Moskowitz, C. H.
    Blood (2009)

    Fulltext@MSK | Save